Carregant...
Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal
The World Health Organization (WHO) recommends that the cost-effectiveness (CE) of introducing new vaccines be considered before such a programme is implemented. However, in low- and middle-income countries (LMICs), it is often challenging to perform and interpret the results of model-based economic...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3117725/ https://ncbi.nlm.nih.gov/pubmed/21569407 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-9-55 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|